{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:25:32Z","timestamp":1788265532661,"version":"build-2803163510"},"reference-count":30,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T00:00:00Z","timestamp":1788048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr. Issues Mol. Biol.","CIMB"],"abstract":"<jats:p>Background and Objective: The objective of this exploratory study was to identify the molecular characteristics that influence survival outcomes in cases of cervical adenocarcinoma, utilising data from the TCGA (The Cancer Genome Atlas) database. Methods: The \u2018TCGA Firehose Legacy\u2019 dataset was accessed through the Cbioportal website. SILVA invasion patterns were independently evaluated on digitized whole-slide images by two gynecologic pathologists. Cases were categorized by overall survival status (living vs. deceased). Somatic mutations, copy number alterations, mRNA expression, RPPA protein expression, and DNA methylation profiles were analyzed. Survival analyses were performed using Kaplan\u2013Meier methods and log-rank tests, supplemented by differential analysis. Pathway and transcription factor binding motif enrichment was evaluated via g:Profiler. p and q &lt; 0.05 were considered statistically significant. Results: Among 27 cases (22 living, 5 deceased; 23 HPV-positive, 2 HPV-negative, 2 unknown), PREX1 protein expression was identified as the top-ranked differentially expressed candidate protein (p = 4.29 \u00d7 10\u22125, q = 8.70 \u00d7 10\u22123). Kaplan\u2013Meier analysis demonstrated superior overall survival in patients with high PREX1 protein levels. DNA methylation analysis identified 8 differentially methylated genes (p, q &lt; 0.05); 7 were hypermethylated in the deceased group (MCEMP1, RNASE2, RINL, CCL17, THBD, SFXN5, PRR19), while WDR89 was hypermethylated in the living group. Enrichment analysis of differentially methylated promoter regions revealed a distinct KLF9-binding regulatory motif (q = 0.032). Due to sample size constraints (n = 2 HPV-negative, n = 2 SILVA Pattern A), subgroup comparisons for HPV status and SILVA patterns were interpreted descriptively without inferential statistical claims. Conclusions: In this exploratory cohort, elevated PREX1 protein levels and promoter hypermethylation of specific immune- and metabolic-related genes were associated with overall survival in endocervical adenocarcinoma. Due to the current lack of independent public proteomic validation datasets, PREX1 emerges as a novel candidate biomarker requiring prospective tissue-based immunohistochemical and epigenetic validation in larger multi-center clinical cohorts.<\/jats:p>","DOI":"10.3390\/cimb48090881","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:33:32Z","timestamp":1788262412000},"page":"881","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Survival-Associated Molecular and Epigenetic Alterations in Endocervical Adenocarcinoma: An Exploratory TCGA Multi-Omics Cohort Study"],"prefix":"10.3390","volume":"48","author":[{"given":"Yasemin","family":"Cakir","sequence":"first","affiliation":[{"name":"Department of Pathology, School of Medicine, Dokuz Eyl\u00fcl University, 35330 \u0130zmir, T\u00fcrkiye"},{"name":"Department of Molecular Pathology, Institute of Health Sciences, Dokuz Eyl\u00fcl University, 35330 \u0130zmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Zeynep","family":"Bayramoglu","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, Dokuz Eyl\u00fcl University, 35330 \u0130zmir, T\u00fcrkiye"},{"name":"Department of Molecular Pathology, Institute of Health Sciences, Dokuz Eyl\u00fcl University, 35330 \u0130zmir, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"106884","DOI":"10.1016\/j.intimp.2020.106884","article-title":"A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma","volume":"88","author":"Liu","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Zahan, U.F., Sohel, H.I., Nakayama, K., Ishikawa, M., Nagase, M., Razia, S., Kanno, K., Yamashita, H., Sonia, S.B., and Kyo, S. (2025). A Comparative Analysis of Usual- and Gastric-Type Cervical Adenocarcinoma in a Japanese Population Reveals Distinct Clinicopathological and Molecular Features with Prognostic and Therapeutic Insights. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26157469"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.critrevonc.2019.01.006","article-title":"Adenocarcinoma of the uterine cervix: Pathologic features, treatment options, clinical outcome and prognostic variables","volume":"135","author":"Gadducci","year":"2019","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/his.13995","article-title":"Cervical adenocarcinoma: Integration of HPV status, pattern of invasion, morphology and molecular markers into classification","volume":"76","author":"Park","year":"2020","journal-title":"Histopathology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/PAS.0000000000001224","article-title":"Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC)","volume":"43","author":"Stolnicu","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Hurjui, R.M., Hurjui, I.A., Bu\u021bureanu, T.A., Popovici, D., Av\u0103d\u0103nei, E.-R., and Balan, R.A. (2025). HPV-Independent Cervical Cancer\u2014A New Challenge of Modern Oncology. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262010051"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Wang, Y., Zhou, X., Xi, Y., Lou, H., Li, L., Yi, H., and Zhu, T. (2025). PET\/CT Imaging Characteristics of Gastric-Type Endocervical Adenocarcinoma: Findings from a Small Exploratory Series. Curr. Oncol., 32.","DOI":"10.3390\/curroncol32100530"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1097\/PGP.0000000000000755","article-title":"The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists","volume":"40","author":"Bosse","year":"2021","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1158\/1078-0432.CCR-23-1078","article-title":"Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets","volume":"29","author":"Friedman","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Toromani, G., Saglimbeni, G.S., Upadhyayula, B.S., Manu, E., Morris, T.J., Hsia, B., and Tauseef, A. (2026). Comprehensive Genomic Characterization of 102 Cervical Adenocarcinoma Tumors. Medicina, 62.","DOI":"10.3390\/medicina62010123"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Fleischmann, M., Chatzikonstantinou, G., Fokas, E., Wichmann, J., Christiansen, H., Strebhardt, K., R\u00f6del, C., Tselis, N., and R\u00f6del, F. (2021). Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer. Cancers, 13.","DOI":"10.3390\/cancers13225748"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kuruma, A., Masuda, T., Sato, K., Kido, K., Motooka, D., Komura, N., Yokoi, T., Yoshihara, K., Kinose, Y., and Hashimoto, K. (2026). Identification of the Carcinogenic Process from Lobular Endocervical Glandular Hyperplasia to Gastric-Type Adenocarcinoma of the Uterine Cervix via Whole-Exome Sequencing. Cancers, 18.","DOI":"10.3390\/cancers18040651"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network (2017). Integrated genomic and molecular characterization of cervical cancer. Nature, 543, 378\u2013384.","DOI":"10.1038\/nature21386"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"W207","DOI":"10.1093\/nar\/gkad347","article-title":"g:Profiler\u2014Interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update)","volume":"51","author":"Kolberg","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1042\/BST20160269","article-title":"P-Rex1 and P-Rex2 RacGEFs and cancer","volume":"45","author":"Srijakotre","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"104676","DOI":"10.1016\/j.phrs.2020.104676","article-title":"The Rho guanine nucleotide exchange factor P-Rex1 as a potential drug target for cancer metastasis and inflammatory diseases","volume":"153","author":"Ye","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10735-020-09901-9","article-title":"Overexpression of PREX1 in oral squamous cell carcinoma indicates poor prognosis","volume":"51","author":"Wan","year":"2020","journal-title":"Histochem. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4537532","DOI":"10.1155\/2017\/4537532","article-title":"P-Rex1 Expression in Invasive Breast Cancer in relation to Receptor Status and Distant Metastatic Site","volume":"2017","author":"Marotti","year":"2017","journal-title":"Int. J. Breast Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/s41388-019-1064-3","article-title":"PREX1 drives spontaneous bone dissemination of ER+ breast cancer cells","volume":"39","author":"Clements","year":"2020","journal-title":"Oncogene"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.12659\/MSM.915845","article-title":"Phosphatidylinositol-3,4,5-Trisphosphate Dependent Rac Exchange Factor 1 (PREX1) is a Novel Predictor of Prognosis for Breast Cancer Patients: A Retrospective Case Series","volume":"25","author":"Zhong","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"103675","DOI":"10.1016\/j.critrevonc.2022.103675","article-title":"Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies","volume":"174","author":"Bhattacharjee","year":"2022","journal-title":"Crit. Rev. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/s41419-020-03244-9","article-title":"HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K\/AKT\/SGK pathway","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/PGP.0000000000000735","article-title":"The Silva Pattern-based Classification for HPV-associated Invasive Endocervical Adenocarcinoma and the Distinction Between In Situ and Invasive Adenocarcinoma: Relevant Issues and Recommendations From the International Society of Gynecological Pathologists","volume":"40","author":"Stolnicu","year":"2021","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1007\/s12253-020-00817-z","article-title":"Prognostic Role of Kr\u00fcppel-Like Factors 5, 9, and 11 in Endometrial Endometrioid Cancer","volume":"26","author":"Viola","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.21037\/tcr.2020.03.53","article-title":"Progesterone receptor inhibits the proliferation and invasion of endometrial cancer cells by up regulating Kr\u00fcppel-like factor 9","volume":"9","author":"Yan","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Xiao, X., Dai, Z., Liu, F., Zhao, X., and Wu, Q. (2025). KLF9 in cancer: A potential prognostic marker and therapeutic target. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1630547"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.1007\/s00432-023-05274-0","article-title":"Expression of four cancer-testis antigens in TNBC indicating potential universal immunotherapeutic targets","volume":"149","author":"Xiao","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3892\/etm.2023.12342","article-title":"KLF9-regulated FBXO31 inhibits the progression of endometrial cancer and enhances the sensitivity of endometrial cancer cells to cisplatin","volume":"27","author":"Yang","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Safi, S., Badshah, Y., Shabbir, M., Zahra, K., Khan, K., Dilshad, E., Afsar, T., Almajwal, A., Alruwaili, N.W., and Al-Disi, D. (2022). Predicting 3D Structure, Cross Talks, and Prognostic Significance of KLF9 in Cervical Cancer. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.797007"}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/9\/881\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:10:31Z","timestamp":1788264631000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/9\/881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,30]]},"references-count":30,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cimb48090881"],"URL":"https:\/\/doi.org\/10.3390\/cimb48090881","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,30]]}}}